 
                        | Product NDC: | 51079-161 | 
| Proprietary Name: | Acetaminophen and Codeine Phosphate | 
| Non Proprietary Name: | Acetaminophen and Codeine Phosphate | 
| Active Ingredient(s): | 300; 30 mg/1; mg/1 & nbsp; Acetaminophen and Codeine Phosphate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 51079-161 | 
| Labeler Name: | Mylan Institutional Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA088628 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120216 | 
| Package NDC: | 51079-161-20 | 
| Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-161-20) > 1 TABLET in 1 BLISTER PACK (51079-161-01) | 
| NDC Code | 51079-161-20 | 
| Proprietary Name | Acetaminophen and Codeine Phosphate | 
| Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-161-20) > 1 TABLET in 1 BLISTER PACK (51079-161-01) | 
| Product NDC | 51079-161 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Acetaminophen and Codeine Phosphate | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20120216 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Mylan Institutional Inc. | 
| Substance Name | ACETAMINOPHEN; CODEINE PHOSPHATE | 
| Strength Number | 300; 30 | 
| Strength Unit | mg/1; mg/1 | 
| Pharmaceutical Classes |